Chemical genetic modifier screens: Small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation

Chemistry and Biology

Volumn 10, Issue 5, 2003, Pages 397-410

  Koeller, Kathryn M ^a   Haggarty, Stephen J ^a   Perkins, Brian D ^a   Leykin, Igor ^b   Wong, Jason C ^a   Kao, Ming Chih J ^b   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037562075     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(03)00093-0     Document Type: Article

References (41)

1. Cress W.C., Seto E. Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184:2000;1-16.
2. Marks P.A., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylases and cancer. causes and therapies Nat. Rev. Cancer. 1:2001;194-202.
3. He L.-Z., Tolentino T., Grayson P., Zhong S., Warrel R.P. Jr., Rifkind R.A., Marks P.A., Richon V.M., Pandolfi P.P. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J. Clin. Invest. 108:2001;1321-1330.
4. Piekarz R.L., Robey R., Sandor V., Bakke S., Wilson W.H., Dahmoush L., Kingma D.M., Turner M.L., Altemus R., Bates S.E. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma. a case report Blood. 98:2001;2865-2868.
5. Hughes R.E. Polyglutamine disease. acetyltransferase awry Curr. Biol. 12:2002;R141-R143.
6. Williams R.S.B., Cheng L., Mudge A.W., Harwood A.J. A common mechanism of action for thee mood-stabilizing drugs. Nature. 417:2002;292-295.
7. Grozinger C.M., Schreiber S.L. Deacetylase enzymes. biological functions and the use of small-molecule inhibitors Chem. Biol. 9:2002;3-16.
8. Yoshida M., Kijama M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:1990;17174-17179.
9. Stockwell B.R., Haggarty S.J., Schreiber S.L. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6:1999;71-83.
10. Haggarty S.J., Mayer T.U., Miyamoto D.T., Fathi R., King R.W., Mitchison T.J., Schreiber S.L. Dissecting cellular processes using small molecules. identification of colchicine-like, taxol-like, and other small molecules that perturb mitosis Chem. Biol. 7:2000;275-286.
11. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., Marks P.A. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. USA. 95:1998;3003-3007.
12. Kim Y.B., Ki S.W., Yoshida M., Horinouchi S. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. J. Antibiot. (Tokyo). 53:2000;1191-1200.
13. Schreiber S.L., Bernstein B.E. Signaling network model of chromatin. Cell. 111:2002;771-778.
14. Kijima M., Yoshida M., Sugita K., Horinouchi S., Beppu T. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268:1993;22429-22435.
15. Nakajima H., Kim Y.B., Terano H., Yoshida M., Horinouchi S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp. Cell Res. 241:1998;126-133.
16. Furumai R., Komatsu Y., Nishino N., Khochbin S., Yoshida M., Horinouchi S. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc. Natl. Acad. Sci. USA. 98:2001;87-92.
17. Guardiola A.R., Yao T.-P. Molecular cloning and characterization of a novel histone deacetylase HDAC10. J. Biol. Chem. 277:2002;3350-3356.
18. Furumai R., Matsuyama A., Kobashi N., Lee K.H., Nishiyama M., Nakajima H., Tanaka A., Komatsu Y., Nishino N., Yoshida M.et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res. 62:2002;4916-4921.
19. Piperno G., LeDizet M., Chang X.-j. Microtubules containing acetylated α-tubulin in mammalian cells in culture. J. Cell Biol. 104:1987;289-302.
20. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.-F., Yao T.-P. HDAC6 is a microtubule-associated deacetylase. Nature. 417:2002;455-458.
21. Haggarty S.J., Koeller K.M., Wong J.C., Butcher R.A., Schreiber S.L. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. Chem. Biol. 10:2003;383-396. this issue,
22. Sternson S.M., Wong J.C., Grozinger C.M., Schreiber S.L. Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org. Lett. 3:2001;4239-4242.
23. Haggarty S.J., Koeller K.M., Wong J.C., Grozinger C.M., Schreiber S.L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. USA. 100:2003;4389-4394.
24. Peterson R.T., Link B.A., Dowling J.E., Schreiber S.L. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA. 97:2000;12965-12969.
25. Hyatt G.A., Schmitt E.A., Fadool J.M., Dowling J.E. Retinoic acid alters photoreceptor development in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;13298-13303.
26. Perkins B.D., Kainz P.M., O'Malley D.M., Dowling J.E. Transgenic expression of a GFP-rhodopsin COOH-terminal fusion protein in zebrafish rod photoreceptors. Vis. Neurosci. 19:2002;257-264.
27. Bernstein B.E., Tong T.K., Schreiber S.L. Genomewide studies of histone deacetylase function in yeast. Proc. Natl. Acad. Sci. USA. 97:2000;13708-13713.
28. Mariadson J.M., Corner G.A., Augenlicht L.H. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids. comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer Cancer Res. 60:2000;4561-4572.
29. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays. expression index computation and outlier detection Proc. Natl. Acad. Sci. USA. 98:2001;31-36.
30. Diamond S.E., Gutierrez-Hartmann A. The pit-1β domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter. J. Biol. Chem. 275:2000;30977-30986.
31. Ammerpohl O., Schmitz A., Steinmiller L., Renkawitz R. Repression of the mouse M-lysozyme gene involves both hindrance of enhancer factor binding to the methylated enhancer and histone deacetylation. Nucleic Acids Res. 26:1998;5256-5260.
32. Fan Z., Beresford P.J., Zhang D., Xu Z., Novina C.D., Yoshida A., Pommier Y., Lieberman J. Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat. Immunol. 4:2003;145-153.
33. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., Melton D.A. "Stemness" transcriptional profiling of embryonic and adult stem cells Science. 298:2002;597-600.
34. Webb Y., Zhou X., Ngo L., Cornish V., Stahl J., Erdjument-Bromage H., Tempst P., Rifkind R.A., Marks P.A., Breslow R.et al. Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents. J. Biol. Chem. 274:1999;14280-14287.
35. Sowa Y., Orita T., Minamikawa S., Nakano K., Mizuno T., Nomura H., Sakai T. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter though the Sp1 sites. Biochem. Biophys. Res. Commun. 241:1997;142-150.
36. Brehm A., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature. 391:1998;597-601.
37. Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J., Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:1999;5099-5107.
38. Taunton J., Hassig C.A., Schreiber S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3. Science. 272:1996;408-411.
39. Qiu L., Burgess A., Fairlie D.P., Leonard H., Parsons P.G., Gabrielli B.G. Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Mol. Biol. Cell. 11:2000;2069-2083.
40. Hassig C.A., Tong J.K., Fleischer T.C., Owa T., Grable P.G., Ayer D.E., Schreiber S.L. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. USA. 95:1998;3519-3524.
41. Westerfeld, M. (1995). The Zebrafish Book, Third Edition (Eugene, OR: University of Oregon Press).